How much do peptide therapies cost?

Peptide therapy costs vary dramatically based on source, peptide type, dosing, and duration. Research peptides from online vendors cost $30-150 per vial depending on the compound and quantity, but quality and safety are uncertain. Pharmaceutical-grade peptides from compounding pharmacies typically cost $150-500 monthly for common protocols like CJC-1295/Ipamorelin or BPC-157. GLP-1 medications (semaglutide, tirzepatide) cost $800-1,600 monthly without insurance, though insurance coverage and manufacturer programs often reduce this. Specialized or newer peptides command premium prices. Cost Plus Drugs offers compounded semaglutide for $180-280 monthly. Insurance generally doesn't cover experimental peptide therapies, though some HSA/FSA accounts may reimburse with appropriate documentation. Long-term costs add up significantly - a year of peptide therapy can cost $2,000-15,000+ depending on protocol complexity. Compared to GLP-1s with established efficacy data, many research peptides offer less proven benefits for substantial cost, making cost-benefit analysis important.